Announcement on Resignation of Independent Director
Filed with SSE · · 2 pages · Chinese
Youcare Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Youcare Pharmaceutical
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Indicative Announcement on Completion of Transfer Registration for Partial Shares Held by Controlling Shareholders Subject to Judicial Auction and Change in Equity Shares Exceeding Integer Multiple of 5%
- Announcement on Voluntary Disclosure of Subsidiary’s YKYY029 Injection Obtaining Clinical Trial Approval from the FDA
- Announcement on Voluntary Disclosure of Subsidiary’s YKYY029 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration
- Announcement on Progress of the 2nd Judicial Auction of a Portion of Company Shares Held by the Controlling Shareholder
Later from Youcare Pharmaceutical
- Announcement on Voluntary Disclosure of Subsidiary’s YKYY013 Injection Obtaining Clinical Trial Approval from the FDA
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Voluntary Disclosure of Subsidiary’s YKYY013 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration
- Announcement on Completing Term Change and Election of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
- Announcement on Voluntary Disclosure of Subholding YKYY018 Inhalation Aerosol's FDA Clinical Trial Approval
Follow Youcare Pharmaceutical into a list and get an email when it puts out news.
Follow Youcare Pharmaceutical